Aspirin dosing for atherosclerotic cardiovascular disease: should we be more ADAPTABLE? COMMENT

被引:0
|
作者
Parker, William A. E. [1 ,2 ]
Storey, Robert F. [1 ,2 ]
机构
[1] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Cardiovasc Res Unit, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England
[2] Sheffield Teaching Hosp NHS Fdn Trust, South Yorkshire Cardiothorac Ctr, Dept Cardiol, Sheffield, S Yorkshire, England
关键词
Aspirin; Atherosclerosis; Thrombosis; Bleeding; Inflammation;
D O I
10.1093/cvr/cvab251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:E123 / E125
页数:3
相关论文
共 50 条
  • [1] Aspirin Dosing in Cardiovascular Disease and Diabetes: Insights From ADAPTABLE
    Aguilar, David
    Davis, Barry R.
    DIABETES CARE, 2024, 47 (01) : 52 - 53
  • [2] Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
    Marquis-Gravel, Guillaume
    Stebbins, Amanda
    Wruck, Lisa M.
    Roe, Matthew T.
    Effron, Mark B.
    Hammill, Bradley G.
    Whittle, Jeff
    VanWormer, Jeffrey J.
    Robertson, Holly R.
    Alikhaani, Jacqueline D.
    Kripalani, Sunil
    Farrehi, Peter M.
    Girotra, Saket
    Benziger, Catherine P.
    Polonsky, Tamar S.
    Merritt, J. Greg
    Gupta, Kamal
    McCormick, Thomas E., III
    Knowlton, Kirk U.
    Jain, Sandeep K.
    Kochar, Ajar
    Rothman, Russell L.
    Harrington, Robert A.
    Hernandez, Adrian F.
    Jones, W. Schuyler
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (04):
  • [3] Anticoagulation dosing in atherosclerotic cardiovascular disease: Is less more?
    Fanaroff, Alexander C.
    Lopes, Renato D.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 83 : 8 - 9
  • [4] Aspirin Dosing in Cardiovascular Disease
    Monach, Paul A.
    Branch-Elliman, Westyn
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08): : 764 - 764
  • [5] Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients
    Benziger, Catherine P.
    Stebbins, Amanda
    Wruck, Lisa M.
    Effron, Mark B.
    Marquis-Gravel, Guillaume
    Farrehi, Peter M.
    Girotra, Saket
    Gupta, Kamal
    Kripalani, Sunil
    Munoz, Daniel
    Polonsky, Tamar S.
    Sharlow, Amber
    Whittle, Jeffrey
    Harrington, Robert A.
    Rothman, Russell L.
    Hernandez, Adrian F.
    Jones, W. Schuyler
    JAMA CARDIOLOGY, 2024, 9 (09) : 808 - 816
  • [6] Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial
    Narcisse, Dennis I.
    Kim, Hwasoon
    Wruck, Lisa M.
    Stebbins, Amanda L.
    Munoz, Daniel
    Kripalani, Sunil
    Effron, Mark B.
    Gupta, Kamal
    Anderson, R. David
    Jain, Sandeep K.
    Girotra, Saket
    Whittle, Jeff
    Benziger, Catherine P.
    Farrehi, Peter
    Zhou, Li
    Polonsky, Tamar S.
    Ahmad, Faraz S.
    Roe, Matthew T.
    Rothman, Russell L.
    Harrington, Robert A.
    Hernandez, Adrian F.
    Jones, W. Schuyler
    DIABETES CARE, 2024, 47 (01) : 81 - 88
  • [7] Aspirin Dosing in Cardiovascular Disease REPLY
    Jones, W. Schuyler
    Wruck, Lisa M.
    Hernandez, Adrian F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08): : 765 - 765
  • [8] Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
    Jones, W. S.
    Mulder, H.
    Wruck, L. M.
    Pencina, M. J.
    Kripalani, S.
    Munoz, D.
    Crenshaw, D. L.
    Effron, M. B.
    Re, R. N.
    Gupta, K.
    Anderson, R. D.
    Pepine, C. J.
    Handberg, E. M.
    Manning, B. R.
    Jain, S. K.
    Girotra, S.
    Riley, D.
    DeWalt, D. A.
    Whittle, J.
    Goldberg, Y. H.
    Roger, V. L.
    Hess, R.
    Benziger, C. P.
    Farrehi, P.
    Zhou, L.
    Ford, D. E.
    Haynes, K.
    VanWormer, J. J.
    Knowlton, K. U.
    Kraschnewski, J. L.
    Polonsky, T. S.
    Fintel, D. J.
    Ahmad, F. S.
    McClay, J. C.
    Campbell, J. R.
    Bell, D. S.
    Fonarow, G. C.
    Bradley, S. M.
    Paranjape, A.
    Roe, M. T.
    Robertson, H. R.
    Curtis, L. H.
    Sharlow, A. G.
    Berdan, L. G.
    Hammill, B. G.
    Harris, D. F.
    Qualls, L. G.
    Marquis-Gravel, G.
    Modrow, M. F.
    Marcus, G. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, : 1981 - 1990
  • [9] Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
    Jones, W. Schuyler
    Mulder, Hillary
    Wruck, Lisa M.
    Pencina, Michael J.
    Kripalani, Sunil
    Munoz, Daniel
    Crenshaw, David L.
    Effron, Mark B.
    Re, Richard N.
    Gupta, Kamal
    Anderson, R. David
    Pepine, Carl J.
    Handberg, Eileen M.
    Manning, Brittney R.
    Jain, Sandeep K.
    Girotra, Saket
    Riley, Danielle
    DeWalt, Darren A.
    Whittle, Jeff
    Goldberg, Ythan H.
    Roger, Veronique L.
    Hess, Rachel
    Benziger, Catherine P.
    Farrehi, Peter
    Zhou, Li
    Ford, Daniel E.
    Haynes, Kevin
    VanWormer, Jeffrey J.
    Knowlton, Kirk U.
    Kraschnewski, Jennifer L.
    Polonsky, Tamar S.
    Fintel, Dan J.
    Ahmad, Faraz S.
    McClay, James C.
    Campbell, James R.
    Bell, Douglas S.
    Fonarow, Gregg C.
    Bradley, Steven M.
    Paranjape, Anuradha
    Roe, Matthew T.
    Robertson, Holly R.
    Curtis, Lesley H.
    Sharlow, Amber G.
    Berdan, Lisa G.
    Hammill, Bradley G.
    Harris, Debra F.
    Qualls, Laura G.
    Marquis-Gravel, Guillaume
    Modrow, Madelaine F.
    Marcus, Gregory M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (21): : 1981 - 1990
  • [10] Why we should not skip aspirin in cardiovascular prevention
    Schroer, K.
    HAMOSTASEOLOGIE, 2016, 36 (01): : 33 - 43